Treatment of myocardial infarction (MI) patients with and without rheumatoid arthritis (RA).
| Treatment | MI with Patients RA, n = 77 | MI Patients without RA, n = 154 | OR (95% CI) |
|---|---|---|---|
| Reperfusion therapy, n (%) | 39 (50) | 73 (47) | 1.19 (0.63, 2.23) |
| Medications during hospitalization, n (%) | |||
| Aspirin | 56 (72) | 127 (81) | 0.44 (0.18, 1.09) |
| ACE inhibitor | 25 (32) | 58 (37) | 0.78 (0.41, 1.48) |
| Beta blocker | 54 (69) | 115 (74) | 0.83 (0.40, 1.71) |
| Statin | 24 (31) | 61 (39) | 0.58 (0.25, 1.30) |
| Other lipid-lowering agents | 0 (0) | 5 (3) | 0.30 (0.0, 1.64) |
| Other antiplatelet agents | 31 (40) | 71 (46) | 0.71 (0.36, 1.38) |
| Medications at discharge, n (%) | |||
| Aspirin | 49 (63) | 99 (63) | 0.93 (0.45, 1.95) |
| ACE inhibitor | 23 (29) | 51 (33) | 0.91 (0.46, 1.78) |
| Beta blocker | 48 (62) | 92 (59) | 1.45 (0.67, 3.13) |
| Statin | 29 (37) | 58 (37) | 1.12 (0.50, 2.48) |
| Other lipid-lowering agents | 0 (0) | 3 (2) | 0.52 (0.0, 3.43) |
| Other antiplatelet agents | 29 (40) | 55 (39) | 1.07 (0.56, 2.09) |
ACE: angiotensin-converting enzyme.